These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7854554)

  • 41. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.
    Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
    Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Low grade intramedullary osteosarcoma. Apropos of 8 cases].
    Katabi M; Anract P; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(3):208-15. PubMed ID: 9005458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
    Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
    J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol.
    Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D
    Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma.
    Longhi A; Pignotti E; Versari M; Asta S; Bacci G
    Oncol Rep; 2003; 10(1):151-5. PubMed ID: 12469162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
    Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
    Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
    Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
    J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy.
    Carrasco CH; Charnsangavej C; Raymond AK; Richli WR; Wallace S; Chawla SP; Ayala AG; Murray JA; Benjamin RS
    Radiology; 1989 Mar; 170(3 Pt 1):839-42. PubMed ID: 2916040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
    Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-term follow-up results after heavy dose chemotherapy of primary malignant bone tumors of the limbs].
    Cui TH
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):307-10. PubMed ID: 8174471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging.
    Lawrence JA; Babyn PS; Chan HS; Thorner PS; Pron GE; Krajbich IJ
    Radiology; 1993 Oct; 189(1):43-7. PubMed ID: 8372217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Certain roentgenological manifestations of osteogenic sarcoma of tubular bones].
    Sviridov SA; Zvekotkina LS; Kuznetsova IP; Lipovich MM
    Vestn Rentgenol Radiol; 1976; (3):14-8. PubMed ID: 1068585
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of chemotherapy on osteosarcoma of the extremities as apparent from conventional roentgenograms.
    den Heeten GJ; Thijn CJ; Kamps WA; Schraffordt Koops H; Oosterhuis JW; Oldhoff J
    Pediatr Radiol; 1986; 16(5):407-11. PubMed ID: 3462651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
    Liu J; Guo W; Yang RL; Tang XD; Yang Y
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of thallium-201 scintigraphy in assessment of neoadjuvant chemotherapy for osteosarcoma].
    Huang ZK; Lou C; Fang XQ
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):769-72. PubMed ID: 20021831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response to Coss-86 neoadjuvant therapy assessed by computed tomography and histology.
    Liszka G; Szendröi M; Szántó J
    Acta Chir Hung; 1992-1993; 33(1-2):109-16. PubMed ID: 1343453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.